Peter Caravan
Clinical trials sponsored by Peter Caravan, explained in plain language.
-
New imaging study peers inside lungs to track scarring treatment
Knowledge-focused Recruiting nowThis study uses special PET and MRI scans to see how immunosuppressive drugs (like mycophenolate or prednisone) affect collagen buildup and tissue damage in the lungs of people with certain types of interstitial lung disease (ILD) that are not idiopathic pulmonary fibrosis. Resea…
Phase: PHASE2 • Sponsor: Peter Caravan • Aim: Knowledge-focused
Last updated May 26, 2026 06:24 UTC
-
New scans aim to predict lung scarring speed
Knowledge-focused Recruiting nowThis study is testing whether special PET and MRI scans can predict how quickly lung scarring (pulmonary fibrosis) will worsen in people with certain lung diseases. Researchers will follow 60 adults for up to 2 years to see if the scans can identify who will develop progressive f…
Phase: PHASE2 • Sponsor: Peter Caravan • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC